BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1475070)

  • 1. Charting the sea of employee addiction.
    Russo V; Halpern Z
    Occup Health Saf; 1992 Dec; 61(12):35-6, 65. PubMed ID: 1475070
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness and benefit-cost of peer-based workplace substance abuse prevention coupled with random testing.
    Miller TR; Zaloshnja E; Spicer RS
    Accid Anal Prev; 2007 May; 39(3):565-73. PubMed ID: 17125723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health promotion in the work-place--beyond an ethnocentric perspective.
    Klingemann HK
    Addiction; 1995 Jul; 90(7):877-81. PubMed ID: 7663310
    [No Abstract]   [Full Text] [Related]  

  • 4. Research on drugs and the workplace: introduction and summary.
    Gust SW; Crouch DJ; Walsh JM
    NIDA Res Monogr; 1990; 100():3-8. PubMed ID: 2132776
    [No Abstract]   [Full Text] [Related]  

  • 5. Survey of employer anti-drug programs.
    Hayghe H
    NIDA Res Monogr; 1990; 100():177-207. PubMed ID: 2132771
    [No Abstract]   [Full Text] [Related]  

  • 6. Testing for drugs of abuse in urine.
    Turk J
    Mo Med; 1989 Jun; 86(6):337-40. PubMed ID: 2755453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance abuse: myths and realities in the corporate sector.
    Merrill JC
    Bus Health; 2001 Jan; 19(1):31, 34-6. PubMed ID: 11200393
    [No Abstract]   [Full Text] [Related]  

  • 8. More employers are utilizing drug-screening programs.
    Bitter J
    Occup Health Saf; 1990 Apr; 59(4):27-32. PubMed ID: 2336234
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug use: association vs causation.
    Ryan J; Zwerling C; Jones M
    J Occup Med; 1993 Oct; 35(10):984. PubMed ID: 8271081
    [No Abstract]   [Full Text] [Related]  

  • 10. Commentary: NIDA's role in applied research.
    DuPont R; Jaffe J; Kleber H
    NIDA Res Monogr; 1990; 100():225-39. PubMed ID: 2132773
    [No Abstract]   [Full Text] [Related]  

  • 11. The effectiveness of preemployment drug screening in the prediction of employment outcome.
    Leigh JP
    J Occup Med; 1993 Oct; 35(10):983-4. PubMed ID: 8271080
    [No Abstract]   [Full Text] [Related]  

  • 12. Ready for the road.
    Schmitt D
    Occup Health Saf; 1996 Mar; 65(3):51-4. PubMed ID: 8851893
    [No Abstract]   [Full Text] [Related]  

  • 13. The results are in: drug testing saves money.
    Battagliola M
    Bus Health; 1993 Aug; 11(9):22-4, 26. PubMed ID: 10127878
    [No Abstract]   [Full Text] [Related]  

  • 14. Control of alcohol and drug abuse in industry--a literature review.
    DuPont RL; Basen MM
    Public Health Rep; 1980; 95(2):137-48. PubMed ID: 6767263
    [No Abstract]   [Full Text] [Related]  

  • 15. Legal aspects of urine screening.
    Schroeder EP
    NIDA Res Monogr; 1989; 95():218-24. PubMed ID: 2640967
    [No Abstract]   [Full Text] [Related]  

  • 16. Targeting substance abuse.
    Gemignani J
    Bus Health; 1997 Feb; 15(2):53-4. PubMed ID: 10172895
    [No Abstract]   [Full Text] [Related]  

  • 17. Rehabilitating workers hooked on drugs.
    Pouzar EA
    Risk Manage; 1991 Mar; 38(3):28-30, 32, 34. PubMed ID: 10170711
    [No Abstract]   [Full Text] [Related]  

  • 18. Study tracks costs of treating employees' drug problems.
    Kim H
    Mod Healthc; 1991 Jan; 21(3):18. PubMed ID: 10170655
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug testing for multiemployer plans: choosing the proper legal structure.
    Barlament JL
    Empl Benefits J; 2004 Mar; 29(1):51-5. PubMed ID: 15069852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the EAP in the identification and treatment of substance abuse.
    Kramer RM
    Clin Lab Med; 1998 Dec; 18(4):747-53, x. PubMed ID: 9891612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.